Drw Securities, LLC Akero Therapeutics, Inc. Call Options Transaction History
Drw Securities, LLC
- $4.23 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding AKRO
# of Institutions
297Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$363 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$309 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$301 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$295 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$244 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.5B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...